{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T09:02:47Z","timestamp":1785661367844,"version":"3.56.0"},"reference-count":62,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>HPV vaccines are among the most effective vaccines available, offering safe administration and high cost-effectiveness. The composition of the vaccines has been changed, involving enrichment with pathogenic strains and extending the possibility of prevention to other HPV-related cancers and diseases. The efficacy of the vaccine extends beyond primary prevention due to documented reductions in the relapse of cervical lesions. The objective of the present study was to evaluate whether there were differences in the frequency of high-grade squamous intraepithelial lesions (H-SILs) and cervical carcinoma between vaccinated and unvaccinated women. This retrospective study included all incident cases of cervical cancer or H-SIL diagnosed between 1 January 2003 and 31 December 2020, in Catania, Italy. We analyzed 2722 cases: 751 cervical cancers and 1901 H-SILs. A total of 88% of patients had never been vaccinated. Among women with H-SILs, 85% had never received a vaccination against HPV. Among the few women with H-SILs who were vaccinated, 3.5% of them received at least one dose of the HPV vaccine before diagnosis, while 96.5% started the HPV vaccine cycle after diagnosis of cervical lesions. The mean age at diagnosis for our population was 43.4 years (52 years for cervical cancer; 39.8 years for H-SIL). Statistically significant differences were found between vaccinated and unvaccinated women. The HPV vaccine is an underutilized intervention that has the potential to eradicate cervical cancer and reduce the occurrence of other HPV-related cancers. Implementing new communication strategies can increase the number of vaccinated subjects.<\/jats:p>","DOI":"10.3390\/ijerph22121844","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:20:57Z","timestamp":1765369257000},"page":"1844","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HPV Vaccine: An Effective but Underutilized Prevention Tool"],"prefix":"10.3390","volume":"22","author":[{"given":"Vittorio","family":"Grieco","sequence":"first","affiliation":[{"name":"Department of Medical, Surgical Sciences and Advanced Technologies, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Fiorito","sequence":"additional","affiliation":[{"name":"Gynecologic and Obstetrics Unit, Azienda Ospedaliero Universitaria Policlinico \u201cG. Rodolico-San Marco\u201d, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4011-9340","authenticated-orcid":false,"given":"Gabriele","family":"Giorgianni","sequence":"additional","affiliation":[{"name":"Department of Prevention, UOS Coordinamento Operativo delle Attivit\u00e0 Vaccinali Metropolitane e Provinciali\u2013ASP 3 Catania, 95027 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Irato","sequence":"additional","affiliation":[{"name":"Integrated Cancer Registry CT-ME-EN, Azienda Ospedaliero Universitaria Policlinico \u201cG. Rodolico-San Marco\u201d, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia Anna","family":"Di Prima","sequence":"additional","affiliation":[{"name":"Integrated Cancer Registry CT-ME-EN, Azienda Ospedaliero Universitaria Policlinico \u201cG. Rodolico-San Marco\u201d, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Chillari","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical Sciences and Advanced Technologies, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6873-5367","authenticated-orcid":false,"given":"Antonella","family":"Ippolito","sequence":"additional","affiliation":[{"name":"School of Specialization in Health Statistics and Biometrics, University of Pavia, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0610-5132","authenticated-orcid":false,"given":"Liliana","family":"Mereu","sequence":"additional","affiliation":[{"name":"Gynecologic and Obstetrics Unit, Azienda Ospedaliero Universitaria Policlinico \u201cG. Rodolico-San Marco\u201d, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0964-3438","authenticated-orcid":false,"given":"Rosalia","family":"Ragusa","sequence":"additional","affiliation":[{"name":"HTA Committee, Azienda Ospedaliero Universitaria Policlinico \u201cG. Rodolico-San Marco\u201d, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.24731","article-title":"Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies","volume":"126","author":"Chan","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_2","unstructured":"WHO (2025, November 01). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240014107."},{"key":"ref_3","unstructured":"(2025, November 01). A Cancer Plan for Europe\u2014European Commission. Available online: https:\/\/commission.europa.eu\/topics\/public-health\/european-health-union\/cancer-plan-europe_en."},{"key":"ref_4","unstructured":"(2025, November 01). WHO Immunization Data Portal\u2014Detail Page. Immunization Data. Available online: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page."},{"key":"ref_5","unstructured":"AIOM (2025, November 01). I Numeri del Cancro in Italia. Available online: https:\/\/www.aiom.it\/wp-content\/uploads\/2024\/12\/2024_NDC-web.pdf."},{"key":"ref_6","unstructured":"Ministero della Salute (2025, November 01). Coperture Vaccinali al 31.12.2024 per HPV, Available online: https:\/\/www.salute.gov.it\/new\/sites\/default\/files\/2025-09\/tabelle%20coperture%20HPV%202024.pdf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/j.vaccine.2010.02.080","article-title":"The Health Technology Assessment of Bivalent HPV Vaccine Cervarix\u00ae in Italy","volume":"28","author":"Chiaradia","year":"2010","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7175\/fe.v13i2S.449","article-title":"HPV vaccination and allocative efficiency: Regional analysis of the costs and benefits with the bivalent AS04-adjuvanted vaccine, from the perspective of public health, for the prevention of cervical cancer and its pre-cancerous lesions","volume":"13","author":"Bonanni","year":"2012","journal-title":"Farmeconomia Health Econ. Ther. Pathw."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Boccalini, S., Ragusa, R., Panatto, D., Calabr\u00f2, G.E., Cortesi, P.A., Giorgianni, G., Favaretti, C., Bonanni, P., Ricciardi, W., and de Waure, C. (2024). Health Technology Assessment of Vaccines in Italy: History and Review of Applications. Vaccines, 12.","DOI":"10.3390\/vaccines12101090"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Rosalik, K., Tarney, C., and Han, J. (2021). Human Papilloma Virus Vaccination. Viruses, 13.","DOI":"10.3390\/v13061091"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kamolratanakul, S., and Pitisuttithum, P. (2021). Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer. Vaccines, 9.","DOI":"10.3390\/vaccines9121413"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"pky045","DOI":"10.1093\/jncics\/pky045","article-title":"Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58","volume":"2","author":"Serrano","year":"2018","journal-title":"JNCI Cancer Spectr."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Cai, X., and Xu, L. (2024). Human Papillomavirus-Related Cancer Vaccine Strategies. Vaccines, 12.","DOI":"10.3390\/vaccines12111291"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0000000000003833","article-title":"Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women: A Systematic Review and Meta-Analysis","volume":"135","author":"Lichter","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Michalczyk, K., Misiek, M., and Chudecka-G\u0142az, A. (2022). Can Adjuvant HPV Vaccination Be Helpful in the Prevention of Persistent\/Recurrent Cervical Dysplasia after Surgical Treatment?\u2014A Literature Review. Cancers, 14.","DOI":"10.3390\/cancers14184352"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Di Donato, V., Caruso, G., Petrillo, M., Kontopantelis, E., Palaia, I., Perniola, G., Plotti, F., Angioli, R., Muzii, L., and Benedetti Panici, P. (2021). Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis. Vaccines, 9.","DOI":"10.3390\/vaccines9050410"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Pino, M.D., Mart\u00ed, C., Torras, I., Henere, C., Munmany, M., Marimon, L., Saco, A., Torn\u00e9, A., and Ordi, J. (2020). HPV Vaccination as Adjuvant to Conization in Women with Cervical Intraepithelial Neoplasia: A Study under Real-Life Conditions. Vaccines, 8.","DOI":"10.3390\/vaccines8020245"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e17723","DOI":"10.15252\/emmm.202317723","article-title":"Full Eradication of Pre-clinical Human Papilloma Virus-induced Tumors by a Lentiviral Vaccine","volume":"15","author":"Douguet","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Nayar, R., and Wilbur, D.C. (2015). The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes, Springer International Publishing. Available online: https:\/\/link.springer.com\/10.1007\/978-3-319-11074-5.","DOI":"10.1007\/978-3-319-11074-5"},{"key":"ref_20","unstructured":"(2025, November 01). International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3). Available online: https:\/\/www.who.int\/standards\/classifications\/other-classifications\/international-classification-of-diseases-for-oncology."},{"key":"ref_21","unstructured":"(2025, November 01). Ministero della Salute\u2014Adolescenti 11\u201318 Anni, Available online: https:\/\/www.salute.gov.it\/new\/it\/tema\/vaccinazioni\/adolescenti-11-18-anni."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"W-163\u2013W-194","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex. Transm. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2431807","DOI":"10.1001\/jamanetworkopen.2024.31807","article-title":"Human Papillomavirus Vaccination and Human Papillomavirus\u2013Related Cancer Rates","volume":"7","author":"Adekanmbi","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/cncr.30588","article-title":"Human Papillomavirus in Cervical Cancer and Oropharyngeal Cancer: One Cause, Two Diseases","volume":"123","author":"Berman","year":"2017","journal-title":"Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2025.03.008","article-title":"Validating the Predicted Impact of HPV Vaccination on HPV Prevalence, Cervical Lesions, and Cervical Cancer: A Systematic Review of Population Level Data and Modelling Studies","volume":"195","author":"Naslazi","year":"2025","journal-title":"Gynecol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The Effects of the National HPV Vaccination Programme in England, UK, on Cervical Cancer and Grade 3 Cervical Intraepithelial Neoplasia Incidence: A Register-Based Observational Study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101304","DOI":"10.1016\/j.ijgc.2024.101304","article-title":"Cervical Lesions and HPV Vaccination Status: Epidemiological Analysis of Population in Province of Catania","volume":"35","author":"Fiorito","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"101872","DOI":"10.1016\/j.pmedr.2022.101872","article-title":"Cost-Effectiveness of a Male Catch-up Human Papillomavirus Vaccination Program in the Netherlands","volume":"28","author":"Simons","year":"2022","journal-title":"Prev. Med. Rep."},{"key":"ref_30","unstructured":"(2025, November 01). La Diffusione Degli Screening Oncologici in Italia Nel 2023|Osservatorio Nazionale Screening. Available online: https:\/\/www.osservatorionazionalescreening.it\/content\/la-diffusione-degli-screening-oncologici-italia-nel-2023."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Canfell, K., Caruana, M., Gebski, V., Darlington-Brown, J., Heley, S., Brotherton, J., Gertig, D., Jennett, C.J., Farnsworth, A., and Tan, J. (2017). Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002388"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41416-020-0850-6","article-title":"Impact of HPV vaccination on cervical screening performance: A population-based cohort study","volume":"123","author":"Lei","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2400820","DOI":"10.2807\/1560-7917.ES.2025.30.27.2400820","article-title":"Human papillomavirus prevalence in first, second and third cervical cell samples from women HPV-vaccinated as girls, Denmark, 2017 to 2024: Data from the Trial23 cohort study","volume":"30","author":"Nonboe","year":"2025","journal-title":"Eurosurveillance"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101203","DOI":"10.1016\/j.lanepe.2024.101203","article-title":"Impact of a national HPV vaccination programme for preadolescent girls on cytology screening performance and CIN2+ incidence: Five-year population-based cervical screening results from Slovenia","volume":"50","author":"Irzaldy","year":"2025","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000528964","article-title":"The Future Role of Cytology in Cervical Cancer Screening in the Era of HPV Vaccination","volume":"67","author":"Barroeta","year":"2023","journal-title":"Acta Cytol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.vaccine.2022.11.057","article-title":"High Vaccine Effectiveness Persists for Ten Years after HPV16\/18 Vaccination among Young Dutch Women","volume":"41","author":"Hoes","year":"2023","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ypmed.2016.11.020","article-title":"Cervical Cancer Screening in Women Vaccinated against Human Papillomavirus Infection: Recommendations from a Consensus Conference","volume":"98","author":"Carozzi","year":"2017","journal-title":"Prev. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41416-024-02681-z","article-title":"Predictable Changes in the Accuracy of Human Papillomavirus Tests after Vaccination: Review with Implications for Performance Monitoring in Cervical Screening","volume":"130","author":"Rebolj","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e29881","DOI":"10.1002\/jmv.29881","article-title":"Criteria for Second Generation Comparator Tests in Validation of Novel HPV DNA Tests for Use in Cervical Cancer Screening","volume":"96","author":"Arbyn","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ijc.32752","article-title":"Risk of Cervical Intraepithelial Neoplasia Grade 2 or Worse after Conization in Relation to HPV Vaccination Status","volume":"147","author":"Sand","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2343552","DOI":"10.1080\/21645515.2024.2343552","article-title":"Reduced Risk of CIN2+ Recurrence in Women Immunized with a 9-Valent HPV Vaccine Post-Excision: Retrospective Cohort Study","volume":"20","author":"Pilka","year":"2024","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejogrb.2021.11.008","article-title":"den If Prophylactic HPV Vaccination Is Considered in a Woman with CIN2+, What Is the Value and Should It Be given before or after the Surgical Treatment?","volume":"269","author":"Tjalma","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13027-023-00547-2","article-title":"Can Prophylactic HPV Vaccination Reduce the Recurrence of Cervical Lesions after Surgery? Review and Prospect","volume":"18","author":"Han","year":"2023","journal-title":"Infect. Agent. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e181999","DOI":"10.1001\/jamanetworkopen.2018.1999","article-title":"Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus\u2013Associated Cancers","volume":"1","author":"Suk","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ragusa, R., Torrisi, A., Di Prima, A.A., Torrisi, A.A., Ippolito, A., Ferrante, M., Madeddu, A., and Guardabasso, V. (2022). Cancer Prevention for Survivors: Incidence of Second Primary Cancers and Sex Differences\u2014A Population-Based Study from an Italian Cancer Registry. Int. J. Environ. Res. Public. Health, 19.","DOI":"10.3390\/ijerph191912201"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1002\/cncr.30828","article-title":"Elevated Risk of Human Papillomavirus-Related Second Cancers in Survivors of Anal Canal Cancer","volume":"123","author":"Nelson","year":"2017","journal-title":"Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1200\/JCO.2008.18.4549","article-title":"Second Cancers After Squamous Cell Carcinoma and Adenocarcinoma of the Cervix","volume":"27","author":"Chaturvedi","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e29600","DOI":"10.2196\/29600","article-title":"Characteristics of and User Engagement With Antivaping Posts on Instagram: Observational Study","volume":"7","author":"Gao","year":"2021","journal-title":"JMIR Public Health Surveill."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.jmig.2021.02.005","article-title":"Health Information in the Era of Social Media: An Analysis of the Nature and Accuracy of Posts Made by Public Facebook Pages for Patients with Endometriosis","volume":"28","author":"Towne","year":"2021","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e21204","DOI":"10.2196\/21204","article-title":"Factors Engaging Users of Diabetes Social Media Channels on Facebook, Twitter, and Instagram: Observational Study","volume":"22","author":"Gabarron","year":"2020","journal-title":"J. Med. Internet Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e2024156","DOI":"10.5826\/dpc.1403a156","article-title":"Influence of Social Media and Internet on Treatment Decisions in Adult Female Acne Patients: A Cross-Sectional Survey Study","volume":"14","author":"Ertekin","year":"2024","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Mari, A., Gianolio, L., Edefonti, V., Khaleghi Hashemian, D., Casini, F., Bergamaschi, F., Sala, A., Verduci, E., Calcaterra, V., and Zuccotti, G.V. (2022). HPV Vaccination in Young Males: A Glimpse of Coverage, Parental Attitude and Need of Additional Information from Lombardy Region, Italy. Int. J. Environ. Res. Public. Health, 19.","DOI":"10.3390\/ijerph19137763"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric Outcomes after Conservative Treatment for Intraepithelial or Early Invasive Cervical Lesions: Systematic Review and Meta-Analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","article-title":"Perinatal Mortality and Other Severe Adverse Pregnancy Outcomes Associated with Treatment of Cervical Intraepithelial Neoplasia: Meta-Analysis","volume":"337","author":"Arbyn","year":"2008","journal-title":"BMJ"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40618-023-02192-3","article-title":"HPV-Related Diseases in Male Patients: An Underestimated Conundrum","volume":"47","author":"Garolla","year":"2024","journal-title":"J. Endocrinol. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Lorini, C., Del Riccio, M., Zanobini, P., Biasio, R.L., Bonanni, P., Giorgetti, D., Ferro, V.A., Guazzini, A., Maghrebi, O., and Lastrucci, V. (2023). Vaccination as a Social Practice: Towards a Definition of Personal, Community, Population, and Organizational Vaccine Literacy. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-16437-6"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lebanova, H., Stoev, S., Naseva, E., Getova, V., Wang, W., Sabale, U., and Petrova, E. (2023). Economic Burden of Cervical Cancer in Bulgaria. Int. J. Environ. Res. Public. Health, 20.","DOI":"10.3390\/ijerph20032746"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Wu, Y.-H., Lai, C.-H., Chien, L., Pan, Y.-C., Lin, Y.-J., Feng, C., and Chang, C.-J. (2023). Economic Burden of Cervical and Head and Neck Cancer in Taiwan from a Societal Perspective. Int. J. Environ. Res. Public. Health, 20.","DOI":"10.3390\/ijerph20043717"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the Cervix Uteri: 2021 Update","volume":"155","author":"Bhatla","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_60","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2377903","DOI":"10.1080\/21645515.2024.2377903","article-title":"Long-Term Effectiveness of the Nine-Valent Human Papillomavirus Vaccine: Interim Results after 12 Years of Follow-up in Scandinavian Women","volume":"20","author":"Kjaer","year":"2024","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jog.16020","article-title":"Human Papillomavirus (HPV) Vaccination in Japan","volume":"50","author":"Miyagi","year":"2024","journal-title":"J. Obstet. Gynaecol. Res."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/22\/12\/1844\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:26:22Z","timestamp":1765369582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/22\/12\/1844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":62,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijerph22121844"],"URL":"https:\/\/doi.org\/10.3390\/ijerph22121844","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]}}}